3D-CRT: THREE-DIMENSIONAL
CONFORMAL RADIATION THERAPY
A clear guide to 3D-CRT โ how CT imaging shapes radiation beams to the exact tumour profile, which cancers it treats, how it compares to IMRT, and how CancerFax helps patients access high-quality treatment in India, China, and internationally.
analyticsAt a Glance
- check_circle3D-CRT shapes each radiation beam to the exact 3D outline of the tumour using CT imaging and multi-leaf collimators.
- check_circleUsed for lung, prostate, breast, liver, brain, and many other cancers โ the standard radiotherapy platform at most centres.
- check_circleThe foundation for more advanced techniques including IMRT and VMAT โ widely available at well-equipped oncology centres globally.
- check_circleAvailable in India (USD 2,000-6,000) and China (USD 3,000-8,000) at a fraction of Western pricing.
What Is 3D-CRT?
Three-Dimensional Conformal Radiation Therapy is a form of external beam radiotherapy in which radiation beams are individually shaped to match the three-dimensional contours of a tumour. Unlike older techniques that delivered rectangular beams covering large volumes of healthy tissue, 3D-CRT uses CT imaging data to customise beam geometry with precision.
โThe term conformal describes how the radiation field conforms to the tumour shape โ not a broad field, but a beam sculpted to match the cancer.โ
CT-Based Tumour Mapping
Treatment begins with a dedicated planning CT with the patient in treatment position. The radiation oncologist delineates the tumour volume and identifies critical structures to protect โ spinal cord, lungs, kidneys, liver, or bowel depending on cancer location.
Multi-Leaf Collimator Beam Shaping
Multi-leaf collimators (MLCs) โ small motorised metal leaves inside the machine โ are arranged into custom shapes matching the tumour outline at each beam angle. Typically 3-7 beams enter from different directions, concentrating dose at the tumour intersection.
3D-CRT vs Older Techniques
Conventional 2D radiotherapy used rectangular beams covering large areas of surrounding healthy tissue. 3D-CRT was the first major advance โ shaping beams to the tumour profile from multiple angles, significantly reducing unnecessary normal tissue exposure.
Foundation for Advanced Techniques
3D-CRT is the technical foundation on which IMRT, VMAT, and SBRT are built. While IMRT adds intensity modulation within the beam, 3D-CRT remains the standard approach for many cancers where the added complexity of IMRT is not clinically necessary.
The 3D-CRT Treatment Process
From planning CT to final session โ the complete treatment journey for 3D-CRT.
- 1
Planning CT Scan and Immobilisation
A dedicated CT scan is taken with the patient in the exact treatment position. Immobilisation devices (body moulds, masks) are fitted to ensure reproducible positioning at each session.
- 2
Tumour Delineation and Organ Contouring
The radiation oncologist outlines the gross tumour volume (GTV), clinical target volume (CTV), and planning target volume (PTV) on the CT scan. Critical organs-at-risk (OARs) are also contoured.
- 3
3D Dose Planning and Beam Selection
Radiation physicists select beam angles and configure MLC leaf positions to conform the dose distribution to the PTV while respecting dose limits for OARs. A dose-volume histogram confirms the plan meets clinical targets.
- 4
Plan Review and Quality Assurance
The radiation oncologist approves the final plan. The medical physics team performs quality assurance measurements to confirm the machine delivers what the computer designed before any patient treatment begins.
- 5
Daily Treatment Sessions
Each session takes 10-20 minutes. The patient lies in the immobilisation device while IGRT imaging confirms position before the beam is delivered. Standard fractionation is 25-35 sessions over 5-7 weeks; hypofractionation uses fewer, larger doses.
Which Cancers Is 3D-CRT Used to Treat?
3D-CRT is used across a wide range of cancer types. It remains the standard approach where IMRT's added complexity offers limited incremental benefit, and is used in combination with surgery, chemotherapy, and other modalities.
Lung Cancer
3D-CRT with or without concurrent chemotherapy is used for locally advanced non-small cell lung cancer and for early-stage disease in medically inoperable patients. It is also used for palliation of symptomatic lung masses.
Prostate Cancer
3D-CRT was the standard for prostate cancer radiotherapy before IMRT became dominant. It is still used at many centres for localised prostate cancer, particularly where MLC-based shaping adequately protects the rectum and bladder.
Breast Cancer
Post-lumpectomy or post-mastectomy radiotherapy for breast cancer, including chest wall, regional nodes, and breast reconstruction boost. 3D-CRT is standard for most breast cancer radiotherapy in non-complex anatomical situations.
Liver, Gastric, Oesophageal, and Pelvic Cancers
3D-CRT is used for locally advanced upper GI and pelvic cancers, typically combined with chemotherapy. It provides adequate conformality for many abdominal and pelvic targets.
3D-CRT vs IMRT: When Each Is Appropriate
Both are evidence-based radiation techniques. The choice depends on tumour complexity, proximity to critical organs, and treatment goals.
Choose 3D-CRT When
- Tumour is accessible without complex beam shapingSimple targets without concave dose distributions or critical organ wrapping.
- Centre expertise and equipment favour 3D-CRTWell-configured 3D-CRT delivers excellent outcomes for many standard indications.
- Lower treatment complexity is appropriateShorter planning time, fewer QA steps, and broadly available at most radiotherapy centres.
- Cost is a primary consideration3D-CRT is less expensive to plan and deliver than IMRT at most centres.
Consider IMRT When
- Tumour is adjacent to critical dose-limiting organsHead and neck, prostate near rectum, brain tumours near optic structures โ IMRT's intensity modulation provides superior OAR protection.
- Concave or complex target shapeTumours wrapping around the spinal cord or encasing critical structures benefit from IMRT's sculpted dose distributions.
- Dose escalation is clinically beneficialIMRT allows higher tumour doses while keeping OAR doses within tolerance โ particularly for head and neck and prostate cancers.
- Reduced late toxicity is the priorityIMRT's superior OAR sparing reduces long-term xerostomia, rectal and urinary morbidity, and other late effects.
3D-CRT Treatment Costs: India and China vs Western Centres
3D-CRT is one of the most widely available and cost-effective radiation techniques globally. India and China offer high-quality treatment at significantly lower prices.
Full 3D-CRT Course (25-35 fractions)
- India (Apollo, TMC, AIIMS)USD 2,000-6,000
- China (Fudan, Sun Yat-sen, PKU)USD 3,000-8,000
- UK / EuropeUSD 15,000-35,000
- USAUSD 25,000-60,000
Key Numbers
- 25-35Typical Treatment FractionsStandard fractionation over 5-7 weeks. Hypofractionation schemes use 15-20 fractions.
- 3-7Beam Angles UsedMultiple beams from different directions concentrate dose at the tumour intersection.
- 10-20 minPer-Session Treatment TimeShorter than IMRT/VMAT, as 3D-CRT uses fewer, simpler beam configurations.
- ~90%Centres Offering 3D-CRTAvailable at virtually all well-equipped radiation oncology centres globally.
How CancerFax Supports Access to 3D-CRT
CancerFax helps patients understand their radiotherapy options and connect with appropriate centres in India, China, and internationally.
- 1
Medical Report Review
We review pathology, imaging, and treatment history to confirm 3D-CRT appropriateness and whether IMRT or other techniques would offer meaningful incremental benefit.
- 2
Centre Matching by Indication and Location
We match patients to centres with specific experience in their cancer type โ accounting for technology, volume, and geographic accessibility.
- 3
Second Opinion Coordination
We facilitate specialist consultations with radiation oncologists to review the treatment plan and confirm whether the proposed technique and dose are appropriate.
- 4
International Logistics
Documentation, translation, visa support, travel planning, accommodation, and follow-up coordination.
Related Guides in the Radiation Therapy Library
Explore in-depth content on radiation therapy techniques and specific indications.
Frequently Asked Questions
About 3D-CRT
Is 3D-CRT the same as IMRT?
No. 3D-CRT and IMRT are related but distinct techniques. 3D-CRT shapes radiation beams to the tumour's outline using multi-leaf collimators but delivers a uniform intensity within each field. IMRT goes further by varying the intensity across each field โ allowing more complex dose distributions that can better protect nearby critical organs. For many cancers, 3D-CRT is entirely adequate; for others, particularly head and neck and prostate cancers, IMRT's additional precision provides clinically meaningful benefits.
How many treatment sessions does 3D-CRT require?
Standard 3D-CRT typically requires 25-35 daily sessions (fractions) delivered Monday to Friday over 5-7 weeks. Hypofractionation schemes, which use fewer but larger doses, are increasingly used for some cancers and may complete treatment in 15-20 sessions. The number of fractions depends on the cancer type, location, and treatment intent.
Is 3D-CRT available in India and China?
Yes. 3D-CRT is available at virtually all well-equipped radiation oncology centres in both India and China. Major centres including Tata Memorial Centre, Apollo Cancer Centres, AIIMS in India, and Fudan University Shanghai Cancer Center, Sun Yat-sen University Cancer Center, and National Cancer Center Beijing in China all offer 3D-CRT as a standard service. Costs are significantly lower than in Western countries.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Exploring Radiotherapy Options for Your Diagnosis?
Upload your medical reports and imaging โ our radiation oncology team will review your case and advise on the most appropriate technique and centre for your specific situation.
This content is for informational purposes only and does not constitute medical advice. All treatment decisions must be made in consultation with a qualified radiation oncologist.